Niederer Kraft Frey acted as Swiss counsel to Sportradar Group. The NKF team was led by Corporate/M&A partner Patrik Peyer (pictured right). Schellenberg Wittmer acted as Swiss legal counsel to the US enterprise
The Pestalozzi team included Christian Leuenberger (Lead Partner - Capital Markets, Corporate/M&A - pictured), Severin Roelli (Partner - Corpoarte/M&A), Manu Ferro (Associate - Banking & Finance).
Mark Branson (pictured) is stepping down as Director of the Swiss Financial Market Supervisory Authority FINMA. He will assume the role of President of the Federal Financial Supervisory Authority BaFin in mid-2021 in Germany. Mark
NKF acted as legal counsel to Swiss Steel Holding in the capital increase and all related proceedings before the courts, FINMA and the Swiss Takeover Board. The NKF team was led by Corporate and Capital
(by Ricardo Cortés-Monroy) I am currently involved in a fascinating project at the university where I study the Classical Antiquity field. It concerns exploring the extent to which representations of women in Augustan literature
VISCHER advised CITIC on all Swiss law matters. The team was led by Benedict F. Christ (partner, corporate/M&A - pictured) and included Lukas Zuest (counsel, head China Desk, corporate/M&A), Aleksandra Simic (
Katja Roth Pellanda, appointed group general counsel in 2020, tells Legalcommunity.ch about her the projects and how she’s reshaping the insurance company legal department
Homburger acted as Swiss counsel to ARYZTA in connection with the transaction. The team was led by partner Claude Lambert (Corporate / M&A - pictured) and comprised associates Marc Hanslin (Corporate / M&A) and David
Davide Borelli (pictured) was promoted to Global Head of Group Data Protection at Panasonic Healthcare Corporation (PHC) Holdings, a conglomerate of companies active in 170 countries in the life sciences, medtech and diagnostics fields. Based in
Novartis announced the appointment of Karen L. Hale (pictured) as Chief Legal Officer. She will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the Executive Committee of Novartis (ECN),
